Jenny J. L. Ho

San Francisco VA Medical Center — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

19h-index1.5kcitations47works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glycosylation and Glycoproteins Research(22), Monoclonal and Polyclonal Antibodies Research(12), Galectins and Cancer Biology(8), Pancreatic and Hepatic Oncology Research(7), Neuroendocrine Tumor Research Advances(7)

Publications47 total

Aberrant expression of MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelial neoplasms of the pancreas
Gastroenterology·2002· 250 cited
Secretion of MUC5AC mucin from pancreatic cancer cells in response to forskolin and VIP
Biochemical and Biophysical Research Communications·2002· 16 cited
Intrahepatic Ductal Hypoplasia and Anomalous Junction of pancreatico-biliary ductal system as causes of choledocal cysts
Gastroenterology·2001
Antibody‐dependent Cytotoxicity Mediated by Chimeric Monoclonal Antibody Nd2 and Experimental Immunotherapy for Pancreatic Cancer
Japanese Journal of Cancer Research·2000· 15 citedOpen Access
Mucin 5AC is upregulated in pancreatic tumors
Gastroenterology·2000· 1 citedOpen Access
Forskolin and phorbol ester have opposite effects on the expression of mucin-associated sialyl-Lewisa in pancreatic cancer cells
European Journal of Cancer·2000· 6 cited
Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: Its relationship with a new morphological classification of cholangiocarcinoma
Hepatology·1999· 154 citedOpen Access
Phorbol Ester Reduces Phosphorylation of Epidermal Growth Factor Receptor in Pancreatic Cancer Cells by Activation of a Tyrosine Phosphatase
Biochemical and Biophysical Research Communications·1999· 4 cited
Preoperative Clinical Radioimmunodetection of Pancreatic Cancer by <sup>111</sup>In‐labeled Chimeric Monoclonal Antibody Nd2
Japanese Journal of Cancer Research·1999· 16 citedOpen Access
Untitled
Annals of Oncology·1999· 2 cited
Biliopancreatic malignancy: Future prospects for progress
Annals of Oncology·1999· 1 citedOpen Access
Mucin gene and antigen expression in biliopancreatic carcinogenesis
Annals of Oncology·1999· 31 cited
Untitled
Annals of Oncology·1999· 9 cited
EGF enhances the effect of vasoactive intestinal hormone in elevating the level of the pancreatic tumor antigen ND2
Gastroenterology·1998· 2 cited
MUC3 Human Intestinal Mucin
Journal of Biological Chemistry·1997· 101 citedOpen Access
Expression of mucin-associated tumor antigens is altered by cell density
International Journal of Cancer·1997· 4 cited
Expression of mucin‐associated tumor antigens is altered by cell density
International Journal of Cancer·1997Open Access
Radioimmunodetection with <sup>111</sup>In–labeled Monoclonal Antibody Nd2 in Patients with Pancreatic Cancer
Japanese Journal of Cancer Research·1997· 11 citedOpen Access
Radioimmunotherapy for Pancreatic Carcinoma Using <sup>131</sup>I‐Labeled Monoclonal Antibody Nd2 in Xenografted Nude Mice
Japanese Journal of Cancer Research·1996· 12 citedOpen Access
Association of sialyl-Lewis(a) and sialyl-Lewis(x) with MUC-1 apomucin ina pancreatic cancer cell line.
PubMed·1995· 52 cited
page 1 of 3Next →

Frequent Co-authors

Young S. Kim(19), Yong Suk Chung(11), Michio Sowa(9), Yoshito Yamashita(7), Bader Siddiki(5), James R. Gum(5), Stephen Rothman(5), Tetsuji Sawada(5), Ellyn Farrelly(5), Suzanne Crawley(4), James C. Byrd(4), Young S. Kim(4), Stanley Meizel(4), Mei Yuan(4), Jian Huang(3), Tetsuji Sawada(3), Y.S. Kim(3), Akimasa Inui(3), Shih–Fan Kuan(2), Suguru Yonezawa(2)